How should I interpret a thyroid panel showing TSH 1.09 µIU/mL, free thyroxine (free T4) 2.38 ng/dL, and total thyroxine (total T4) 17.1 µg/dL?

Thyroid Panel Interpretation

Your thyroid panel shows a normal TSH (1.09 µIU/mL) but elevated free T4 (2.38 ng/dL) and total T4 (17.1 µg/dL), which represents a discordant pattern requiring immediate investigation for assay interference, medications affecting thyroid binding proteins, or the syndrome of inappropriate TSH secretion (SITSH).

Initial Assessment Algorithm

Step 1: Rule Out Laboratory Interference

This discordant pattern—normal TSH with elevated thyroid hormones—is frequently artifactual rather than representing true thyroid dysfunction 1. You must systematically exclude:

• Medications causing assay interference: Heparin therapy can spuriously elevate free T4 measurements through generation of non-esterified fatty acids during sample storage 2. Review all current medications, particularly those known to affect thyroid hormone binding.

• Thyroid hormone autoantibodies (THAA): Present in approximately 2.3% of patients with thyroid disease, these antibodies interfere with radioimmunoassay methods and produce inappropriately elevated free T4 and T3 values 1. Request immune precipitation testing with labeled T4 analog tracer to detect THAA.

• Heterophilic antibodies (HAMA): These can spuriously elevate TSH in immunometric assays, though your TSH is normal, making this less likely 1.

• Familial dysalbuminemic hyperthyroxinemia or abnormal albumin: Rare conditions that elevate total T4 while free T4 should be normal, though assay methods may report falsely elevated free T4 3, 1.

Step 2: Medication and Supplement Review

Critical medications to identify:

• Levothyroxine or thyroid hormone supplementation (exogenous source)
• Amiodarone (can elevate free T4 in euthyroid patients) 3
• Biotin supplements (cause significant assay interference in many immunoassays) 4
• Estrogen/oral contraceptives (increase TBG, elevating total T4 but not typically free T4)

Step 3: Consider SITSH (Syndrome of Inappropriate TSH Secretion)

If assay interference is excluded, SITSH represents a newly recognized entity with significant clinical implications 5. This condition—characterized by elevated free T4 with normal or elevated TSH—was previously underdiagnosed but is now associated with:

• 2-fold increased risk of hypertension (OR 2.00 with Abbott assays, OR 1.70 with Siemens) 5
• 2.65-fold increased risk of diabetes (OR 2.65 with Abbott assays, OR 1.68 with Siemens) 5

SITSH may indicate:

• TSH-secreting pituitary adenoma (rare)
• Thyroid hormone resistance syndrome
• Assay-specific measurement issues with age- and sex-specific reference ranges 5

Step 4: Repeat Testing Protocol

Repeat thyroid function tests within 2-4 weeks 6, specifically requesting:

1. TSH and free T4 using a different assay method (if possible, use a different manufacturer's platform to identify method-specific interference) 4
2. Total T3 or free T3 to assess for T3 toxicosis
3. Thyroid-binding globulin (TBG) level to calculate T4/TBG ratio 7
4. Anti-thyroid antibodies if not previously measured

Clinical Context Matters

Assess for hyperthyroid symptoms despite normal TSH:

• Tachycardia, palpitations, atrial fibrillation
• Weight loss, heat intolerance, tremor
• Anxiety, insomnia

If symptomatic: This discordance becomes more concerning for true thyroid dysfunction (SITSH or central hyperthyroidism) rather than laboratory artifact.

If asymptomatic: Laboratory interference is more likely, but metabolic screening for hypertension and diabetes is warranted given SITSH associations 5.

Common Pitfalls to Avoid

• Do not initiate antithyroid treatment based on a single discordant result without excluding assay interference—this is the most critical error 4.

• Do not assume free T4 assays are infallible: Current free T4 estimation methods are susceptible to numerous interferences, and total T4 corrected for TBG may actually be more reliable 2.

• Do not ignore age- and sex-specific reference ranges: Standard manufacturer reference ranges may misclassify thyroid status, particularly in middle-aged and older individuals 5.

• Do not overlook biotin supplementation: Patients often fail to report over-the-counter supplements, yet biotin causes profound assay interference requiring 48-72 hour washout before retesting 4.

Immediate Next Steps

Order the following tests now:

1. Repeat TSH and free T4 on a different assay platform (specify "no biotin interference" method if available)
2. Total T3 or free T3
3. TBG level
4. Thyroid hormone autoantibody testing (immune precipitation method)
5. Complete medication reconciliation including all supplements

Clinical monitoring:

• Blood pressure measurement
• Fasting glucose or HbA1c (given SITSH metabolic associations)
• Cardiac evaluation if any symptoms of tachycardia or arrhythmia

This pattern requires definitive explanation before any therapeutic intervention, as treatment decisions based on artifactual results can cause significant harm through unnecessary thyroid suppression or ablation 6, 4.